Microbot Medical Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 2.476 million compared to USD 1.884 million a year ago. Net loss was USD 2.511 million compared to USD 1.855 million a year ago. Basic loss per share from continuing operations was USD 0.35 compared to USD 0.26 a year ago. For the half year, operating loss was USD 4.868 million compared to USD 4.047 million a year ago. Net loss was USD 4.899 million compared to USD 4.060 million a year ago. Basic loss per share from continuing operations was USD 0.69 compared to USD 0.57 a year ago.